| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 273.507.289 $ | +16.102.200 $ | +50,3 % | 13 | 255.678.451 $ | +255.678.451 $ | 12 | |||||
| Cogent Biosciences, Inc. | COGT | → 0 | Neutral | 45.061.783 $ | +3.477.098 $ | +8,4 % | 1 | 41.584.685 $ | +41.584.685 $ | 1 | |
| Syndax Pharmaceuticals Inc | SNDX | → 0 | Schwach | 43.332.800 $ | +4.359.250 $ | +11,2 % | 1 | 38.973.550 $ | +38.973.550 $ | 1 | |
| Celldex Therapeutics, Inc. | CLDX | → 0 | Schwach | 27.437.800 $ | +3.944.400 $ | +16,8 % | 1 | 23.493.400 $ | +23.493.400 $ | 1 | |
| Viridian Therapeutics, Inc.\DE | VRDN | → 0 | Schwach | 10.463.250 $ | -16.257.347 $ | -60,8 % | 1 | 26.720.597 $ | +26.720.597 $ | 1 | |
| Vera Therapeutics, Inc. | VERA | → 0 | Neutral | 19.410.975 $ | -5.022.825 $ | -20,6 % | 1 | 24.433.800 $ | +24.433.800 $ | 1 | |
| CytomX Therapeutics, Inc. | CTMX | → 0 | Schwach | 21.385.000 $ | +18.403.000 $ | +617,1 % | 1 | ||||
| KalVista Pharmaceuticals, Inc. | KALV | → 0 | 20.558.769 $ | +7.617.774 $ | +58,9 % | 1 | 12.940.995 $ | +12.940.995 $ | 1 | ||
| CG Oncology, Inc. | CGON | → 0 | Neutral | 19.749.024 $ | -699.576 $ | -3,4 % | 1 | 20.448.600 $ | +20.448.600 $ | 1 | |
| Vaxcyte, Inc. | PCVX | → 0 | Neutral | 18.391.815 $ | +4.942.005 $ | +36,7 % | 1 | 13.449.810 $ | +13.449.810 $ | 1 | |
| BIOCRYST PHARMACEUTICALS INC | BCRX | → 0 | Stark | 9.520.000 $ | -7.250.000 $ | -43,2 % | 1 | 16.770.000 $ | +16.770.000 $ | 1 | |
| Pharvaris N.V. | PHVS | → 0 | Neutral | 13.439.938 $ | +237.875 $ | +1,8 % | 1 | 13.202.063 $ | +13.202.063 $ | 1 | |
| Tyra Biosciences, Inc. | TYRA | → 0 | Schwach | 13.405.000 $ | +4.203.500 $ | +45,7 % | 1 | ||||
| Beam Therapeutics Inc. | BEAM | → 0 | Neutral | 11.351.135 $ | -1.852.954 $ | -14,0 % | 1 | 13.204.089 $ | +13.204.089 $ | 1 | |
| DYNAVAX TECHNOLOGIES CORP | DVAX | → 0 | 10.456.862 $ | +10.456.862 $ | 1 | ||||||
| 273.507.289 $ | +16.102.200 $ | +50,3 % | 13 | 255.678.451 $ | +255.678.451 $ | 12 | |||||